These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9236955)

  • 21. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study.
    Vogel A; Bhattacharya S; Waldorff FB; Waldemar G
    Int Psychogeriatr; 2012 Jan; 24(1):82-9. PubMed ID: 21729415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
    Cummings JL; Ferris SH; Farlow MR; Olin JT; Meng X
    Dement Geriatr Cogn Disord; 2010; 29(5):406-12. PubMed ID: 20502014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.
    Morris JC; Ernesto C; Schafer K; Coats M; Leon S; Sano M; Thal LJ; Woodbury P
    Neurology; 1997 Jun; 48(6):1508-10. PubMed ID: 9191756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study.
    Sousa MF; Santos RL; Nogueira ML; Belfort T; Rosa RD; Torres B; Simões P; Mograbi DC; Laks J; Dourado MC
    J Alzheimers Dis; 2015; 43(3):905-13. PubMed ID: 25125460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials.
    Cummings JL; Raman R; Ernstrom K; Salmon D; Ferris SH;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S147-51. PubMed ID: 17135808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis.
    Ippen CG; Olin JT; Schneider LS
    Am J Geriatr Psychiatry; 1999; 7(4):321-30. PubMed ID: 10521165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
    Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
    Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
    Agüera-Ortiz L; Frank-García A; Gil P; Moreno A;
    Int Psychogeriatr; 2010 Dec; 22(8):1265-79. PubMed ID: 20849672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
    Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study.
    Ott BR; Noto RB; Fogel BS
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):41-6. PubMed ID: 8845700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary incontinence in Alzheimer's disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living.
    Na HR; Park MH; Cho ST; Lee BC; Park S; Kim KH; Choi JB
    Asia Pac Psychiatry; 2015 Mar; 7(1):113-20. PubMed ID: 23857871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of outcome in clinical trials in Alzheimer's disease.
    Snowden JS
    Neuroepidemiology; 1990; 9(4):216-22. PubMed ID: 2215846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.